Featured

Syndax Appoints Steven Closter as Chief Commercial Officer

Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of... Read more »

MapLight Therapeutics Appoints Vishwas Setia as Chief Financial Officer

MapLight Therapeutics, a clinical-stage biopharmaceutical company working to develop targeted novel therapeutics to... Read more »

Evry Health Appoints Christina Rassi as Chief Growth Officer

DALLAS--(BUSINESS WIRE)--Evry Health, a tech-forward business-to-business health insurance company, announced the... Read more »

citybiz
Gain exposure through our multi-channel news platform.

Madrigal Pharmaceuticals Prices of Upsized $600 Million Public Offering

GranaGard Launches the Future of Brain Health: Omega-5 Antioxidants with Nanotechnology for Maximum Brain Health

Acurx Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

Spyre Therapeutics Announces $180 Million Private Placement

NRx Pharmaceuticals Announces Plan to Distribute Shares of HOPE Therapeutics and Royalty Rights on Ketamine Sales to Existing NRx Shareholders

Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics

bluebird bio Secures up to $175 Million Debt Financing with Hercules Capital

Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights

Cellino Appoints Ed Tekeian as Senior Vice President of Engineering

Bristol Myers Squibb Completes Acquisition of PureTech’s Founded Entity Karuna Therapeutics for $14 Billion

Checkpoint Therapeutics Appoints Amit Sharma, M.D. to Board of Directors

2024’s Best & Worst States for Doctors – WalletHub Study

Fulcrum Therapeutics Appoints Patrick Horn M.D., Ph.D., as Chief Medical Officer

Syndax Appoints Steven Closter as Chief Commercial Officer

GRO Biosciences Appoints Tracey Lodie, PhD as Chief Development Officer